Rapporten - SBU

Referenser
1. McCracken JT, McGough J, Shah B,
Cronin P, Hong D, Aman MG, et al.
Risperidone in children with autism and
serious behavioral problems. N Engl J
Med 2002;347:314-21.
2. Shea S, Turgay A, Carroll A, Schulz M,
Orlik H, Smith I, Dunbar F. Risperidone
in the treatment of disruptive behavioral
symptoms in children with autistic and
other pervasive developmental disorders.
Pediatrics 2004;114:e634-41.
3. McDougle CJ, Holmes JP, Carlson DC,
Pelton GH, Cohen DJ, Price LH. A double-
blind, placebo-controlled study of risperidone
in adults with autistic disorder and
other pervasive developmental disorders.
Arch Gen Psychiatry 1998;55:633-41.
4. Nagaraj R, Singhi P, Malhi P. Risperidone
in children with autism: randomized,
placebo-controlled, double-blind study.
J Child Neurol 2006;21:450-5.
5. Aman MG, Singh NN, Stewart AW,
Field CJ. The aberrant behavior checklist.
Psychopharmacol Bull 1985;21:845-9.
6. Guy W. Clinical global impression.
Rockville, MD: National Institute of
Mental Health; 1976. (DHEW Publ
No ADM 76-338).
7. Jesner OS, Aref-Adib M, Coren E.
Risperidone for autism spectrum disorder.
Cochrane Database of Systematic Reviews
2007, Issue 1. Art. No.: CD005040. DOI:
10.1002/14651858.CD005040.pub2.
8. De Hert M, Dobbelaere M,
Sheridan EM, Cohen D, Correll CU.
Metabolic and endocrine adverse effects
of second-generation antipsychotics in
children and adolescents: A systematic
review of randomized, placebo controlled
trials and guidelines for clinical practice.
Eur Psychiatry 2011;26:144-58.
9. Maayan L, Correll CU. Weight gain and
metabolic risks associated with antipsychotic
medications in children and adolescents.
J Child Adolesc Psychopharmacol 2011;
21:517-35.
10. McPheeters ML, Warren Z, Sathe N,
Bruzek JL, Krishnaswami S, Jerome RN,
Veenstra-Vanderweele J. A systematic
review of medical treatments for children
with autism spectrum disorders. Pediatrics
2011;127:e1312-21.
11. Warren J, Veenstra-Vanderweele Z,
Stone W, Bruzek JL, Nahmias AS, Foss-
Feig JH, et al. Therapies for children
with autism spectrum disorders.
Nashville: Vanderbilt Evidence-based
Practice Center Nashville, TN under
Contract No. 290-2007-10065-I.)
AHRQ Publication No. 11-EHC029-EF.
Rockville, MD: Agency for Healthcare
Research and Quality. April 2011.
Available at: www.effectivehealthcare.
ahrq.gov/reports/final.cfm.; 2011.
280 Autismspektrumtillstånd – diAgnostik och insAtser,
vårdens orgAnisAtion och pAtientens delAktighet